Doxazosin Tablet
Product Images NDC 23155-095

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 23155-095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C2bacf15 E521 4d06 B4c6 45b40036b73c 01

Chemical structure of the active ingredient doxazosin, including the doxazosin molecule and a methanesulfonic acid component.*

FDA Label Image

C2bacf15 E521 4d06 B4c6 45b40036b73c 02

A combined data table and bar graph presenting symptom score and maximum flow rate results from three clinical studies comparing placebo and doxazosin at various doses (4 mg and 8 mg). The table shows mean baseline and mean change values for symptom score and maximum flow rate, and the associated bar graph depicts maximum flow rate changes in study 2 for placebo, 4 mg, and 8 mg doxazosin.*

FDA Label Image

C2bacf15 E521 4d06 B4c6 45b40036b73c 03

Two line graphs comparing Doxazosin 8 mg to placebo over 14 weeks. The left graph shows mean change in total symptom score from baseline, with Doxazosin showing greater symptom improvement. The right graph shows mean increase in maximum urinary flow rate, with Doxazosin showing higher flow rate improvements than placebo. Both graphs plot change against duration of treatment in weeks and include statistical significance markers.*

FDA Label Image

C2bacf15 E521 4d06 B4c6 45b40036b73c 04

FDA Label Image

C2bacf15 E521 4d06 B4c6 45b40036b73c 05

FDA Label Image

C2bacf15 E521 4d06 B4c6 45b40036b73c 06

Doxazosin Tablets USP 1 mg by Avet Pharma are oral tablets in a package containing 100 tablets. The label includes dosage and storage instructions, NDC number 23155-092-01, and states 'Rx only' with Heritage Pharmaceuticals Inc. as the labeler d/b/a Avet Pharmaceuticals Inc. It features the Avet Pharma logo and indicates the package contains no varnish.*

FDA Label Image

C2bacf15 E521 4d06 B4c6 45b40036b73c 07

Doxazosin Tablets, USP 2 mg oral tablets packaging label by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label states the package contains 100 tablets, is prescription only (Rx only), and includes usage and storage instructions, a barcode, and a NDC number 23155-093-01. The label also notes the product does not contain varnish.*

FDA Label Image

C2bacf15 E521 4d06 B4c6 45b40036b73c 08

Doxazosin Tablets USP 4 mg oral tablets label from Avet Pharmaceuticals Inc. The label states the strength as 4 mg, package count as 100 tablets, and Rx only. Includes storage and dispensing instructions, barcode, NDC 23155-094-01, and no varnish coating note.*

FDA Label Image

C2bacf15 E521 4d06 B4c6 45b40036b73c 09

Label for Doxazosin Tablets, USP 8 mg by Avet Pharma. The label indicates a bottle containing 100 tablets for oral use, prescription only, manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label includes dosing and storage instructions, barcode, and warnings to keep medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.